429 related articles for article (PubMed ID: 32813275)
1. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.
Naqvi IA; Kamal AK; Rehman H
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD009716. PubMed ID: 32813275
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
Cochrane A; Chen C; Stephen J; Rønning OM; Anderson CS; Hankey GJ; Al-Shahi Salman R
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012144. PubMed ID: 36700520
[TBL] [Abstract][Full Text] [Related]
3. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012584. PubMed ID: 30019463
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.
Kamal AK; Naqvi I; Husain MR; Khealani BA
Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD008076. PubMed ID: 21249700
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin.
De Schryver EL; Algra A; Kappelle LJ; van Gijn J; Koudstaal PJ
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001342. PubMed ID: 22972051
[TBL] [Abstract][Full Text] [Related]
6. Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.
Wang T; Luo J; Wang X; Yang K; Jadhav V; Gao P; Ma Y; Zhao N; Jiao L
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013267. PubMed ID: 32789891
[TBL] [Abstract][Full Text] [Related]
7. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD010693. PubMed ID: 29197071
[TBL] [Abstract][Full Text] [Related]
12. Marine-derived n-3 fatty acids therapy for stroke.
Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD012815. PubMed ID: 35766825
[TBL] [Abstract][Full Text] [Related]
13. Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.
Luo J; Wang T; Yang K; Wang X; Xu R; Gong H; Zhang X; Wang J; Yang R; Gao P; Ma Y; Jiao L
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013267. PubMed ID: 36738471
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD010693. PubMed ID: 36625492
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
18. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.
Squizzato A; Bellesini M; Takeda A; Middeldorp S; Donadini MP
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005158. PubMed ID: 29240976
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet agents for the treatment of deep venous thrombosis.
Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
